Evidence map›Paper›PMID 37808873›Full record

ArticlebioRxiv : the preprint server for biology2023

CELLULAR RNA INTERACTS WITH MAVS TO PROMOTE ANTIVIRAL SIGNALING.

Nandan S Gokhale, Kim Somfleth, Matthew G Thompson, Russell K Sam, Daphnée M Marciniak, Lan H Chu, Moonhee Park, Steve Dvorkin, Andrew Oberst, Stacy M Horner and 3 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Nandan S GokhaleDepartment of Immunology, University of Washington, Seattle, WA.
Kim SomflethDepartment of Immunology, University of Washington, Seattle, WA.
Matthew G ThompsonDepartment of Integrative Immunobiology, Duke University, Durham, NC.
Russell K SamDepartment of Immunology, University of Washington, Seattle, WA.
Daphnée M MarciniakDepartment of Pharmacology, University of Washington, Seattle, WA.
Lan H ChuDepartment of Immunology, University of Washington, Seattle, WA.
Moonhee ParkDepartment of Integrative Immunobiology, Duke University, Durham, NC.
Steve DvorkinDepartment of Immunology, University of Washington, Seattle, WA.
Andrew OberstDepartment of Immunology, University of Washington, Seattle, WA.
Stacy M HornerDepartment of Integrative Immunobiology, Duke University, Durham, NC.
Shao-En OngDepartment of Pharmacology, University of Washington, Seattle, WA.
Michael GaleDepartment of Immunology, University of Washington, Seattle, WA.
Ram SavanDepartment of Immunology, University of Washington, Seattle, WA.
University of Washington · USDuke University · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Innate Immune Regulation of Zika Virus InfectionR01AI145296 · NIAID · UNIVERSITY OF WASHINGTON · PI COYNE, CAROLYN B, DIAMOND, MICHAEL S · 2019 to 2023
$4.1M
ZBP1 activationR01AI153246 · NIAID · UNIVERSITY OF WASHINGTON · PI OBERST, ANDREW ATWELL · 2021 to 2025
$3.1M
Prenylation in antiviral immunityR01AI175724 · NIAID · UNIVERSITY OF WASHINGTON · PI Ram Savan · 2023 to 2026
$2.5M
Regulation of RIG-I signaling and viral immune evasion by ufmylationR01AI155512 · NIAID · DUKE UNIVERSITY · PI HORNER, STACY MICHELLE · 2021 to 2025
$2.3M
Basic Training at the Intersection of Innate and Adaptive Immunity in DiseaseT32AI106677 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL, GOVERMAN, JOAN M · 2013 to 2022
$2.1M
Supplement to DEFINING PATHWAY-SPECIFIC KINASE SIGNALING MODULES WITH PROTEOMICSR01GM129090 · NIGMS · UNIVERSITY OF WASHINGTON · PI ONG, SHAO-EN · 2019 to 2022
$1.7M
A NanoLC-Orbitrap Tribrid Instrument for Comprehensive Proteomics AnalysesS10OD021502 · OD · UNIVERSITY OF WASHINGTON · PI ONG, SHAO-EN · 2017 to 2017
$906k
Regulation of cardiomyocyte inflammation during viral infectionR21AI141823 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2020 to 2021
$507k
Host inflammatory response to SARS-CoV-2R21AI158788 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2021 to 2022
$485k
The splicing factor CELF2 suppresses RNA ligands sensed by RIG-I-like receptorR21AI176442 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2023 to 2024
$485k
Regulation of the MAVS Signalosome by RNA and RNA-binding ProteinsK99AI175483 · NIAID · UNIVERSITY OF WASHINGTON · PI GOKHALE, NANDAN SATISH · 2023 to 2024
$231k
NIAID NIH HHS K99 AI175483NIAID NIH HHS R01 AI145296NIAID NIH HHS R01 AI153246NIAID NIH HHS R01 AI155512NIAID NIH HHS R01 AI175724NIAID NIH HHS R21 AI141823NIAID NIH HHS R21 AI158788NIAID NIH HHS R21 AI176442NIAID NIH HHS T32 AI106677NIGMS NIH HHS R01 GM129090NIH HHS P51 OD010425NIH HHS S10 OD021502
6 · The paper itself

Abstract

Immune signaling needs to be well-regulated to promote clearance of pathogens, while preventing aberrant inflammation. Interferons (IFNs) and antiviral genes are activated by the detection of viral RNA by RIG-I-like receptors (RLRs). Signal transduction downstream of RLRs proceeds through a multi-protein complex organized around the central adaptor protein MAVS. Recent work has shown that protein complex function can be modulated by RNA molecules providing allosteric regulation or acting as molecular guides or scaffolds. Thus, we hypothesized that RNA plays a role in organizing MAVS signaling platforms. Here, we show that MAVS, through its central intrinsically disordered domain, directly interacts with the 3' untranslated regions of cellular mRNAs. Importantly, elimination of RNA by RNase treatment disrupts the MAVS signalosome, including newly identified regulators of RLR signaling, and inhibits phosphorylation of the transcription factor IRF3. This supports the hypothesis that RNA molecules scaffold proteins in the MAVS signalosome to induce IFNs. Together, this work uncovers a function for cellular RNA in promoting signaling through MAVS and highlights a generalizable principle of RNA regulatory control of cytoplasmic immune signaling complexes.

Identifiers

PMID37808873
PMCPMC10557580
OpenAlexW4387058661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.